USA v. Chan
Case Number:
1:16-cr-10268
Court:
Nature of Suit:
Firms
Companies
Sectors & Industries:
-
November 17, 2021
Convicted Insider Trader Must Disclose Atty Communications
A former biotech employee convicted of insider trading must turn over his communications with his attorney if he wants to continue pressing claims that the lawyer's alleged missteps cost him at trial, a Massachusetts federal judge ruled Wednesday.
-
November 13, 2018
Ex-Merrimack Analyst Gets 6 Months For Insider Trading
A former biostatistician at Merrimack Pharmaceuticals Inc. was sentenced to six months in prison and one year of supervised release Tuesday after he maintained his innocence on insider trading charges in Boston federal court.
-
October 12, 2018
2 Fraud-Convicted Pharma Analysts Denied Acquittal Bids
A Massachusetts federal judge on Friday rejected a plea for acquittal and a new trial by two pharmaceutical statisticians awaiting sentencing for securities fraud, denying their argument that prosecutors improperly presented evidence of two separate stock tip conspiracies to a jury after saying they would present just one.
-
September 24, 2018
Ex-Akebia Analyst Jailed For Ignoring Probation Calls
A former biostatistician at Akebia Therapeutics Inc. will await sentencing for an insider trading conviction from behind bars after a fed-up Massachusetts federal judge ordered him jailed Monday for ignoring repeated calls from probation, even as he frequently chatted with his co-conspirator.
-
August 01, 2018
Insider Trader Can't Get Passport Back Ahead Of Sentencing
Convicted insider trader Schultz "Jason" Chan, whom prosecutors last year accused of trying to flee to China, can't get his passport back in connection with an effort to renew his driver's license, a Massachusetts federal judge ruled Wednesday.
-
July 25, 2018
Pharma Statisticians Say Insider Trading Trial Was Tainted
Two statisticians convicted of swapping confidential stock tips about their pharma employers' test-stage drugs asked a Massachusetts federal court Tuesday to replace their insider trading convictions with judgments of acquittal, saying the evidence shown to the jury diverged from federal prosecutors' charges.
-
July 10, 2018
Ex-Akebia, Merrimack Analysts Found Guilty Of Insider Trades
A Massachusetts federal jury debated for less than an hour Tuesday before convicting two former biostatisticians at Akebia Therapeutics Inc. and Merrimack Pharmaceuticals Inc. of swapping confidential information on their companies' investigational drugs to make illegal trades.
-
July 06, 2018
Ex-Akebia Employee Denies Trading On Drug Trial Results
A former biostatistician at Akebia Therapeutics Inc. said Friday at his insider trading trial in Boston that prosecutors have failed to show he purchased stock based on positive results of the company's anemia treatment.
-
July 05, 2018
Insider-Trading Suspect Says He Lied To Friend, Not Feds
A highly educated biostatistician on trial in Massachusetts federal court for insider trading testified Thursday that he compulsively invested in pharmaceutical stocks in the years before he joined Akebia Therapeutics Inc. in 2015, but denied that what he described as meticulously researched purchases violated securities laws.
-
July 03, 2018
Feds Rework 'Misleading' Key Data For Insider-Trading Trial
Federal prosecutors in Boston worked late into Monday night to rework key evidence of stock trades a judge previously found misleading, but were allowed on Tuesday to introduce the data that's central to their case against two biostatisticians on trial for securities fraud.